[Asia Economy Reporter Ji Yeon-jin] Gobiolab announced on the 4th that it has acquired a patent for a composition for the prevention and treatment of immune and metabolic diseases using strains independently discovered from Koreans.
This patent utilizes a newly discovered Bacteroides vulgatus strain from Koreans to suppress obesity and metabolic diseases and has immune regulatory functions. It can be applied to products for the prevention, treatment, or improvement of metabolic diseases including obesity.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
